DIN 02540193 — ADTRALZA 300 MG
ADTRALZA is a solution of Tralokinumab marketed by LEO PHARMA INC. The full Tralokinumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02540193
- Brand name
- ADTRALZA
- Active ingredient
- Tralokinumab
- Strength
- 300 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- LEO PHARMA INC
- Health Canada status
- MARKETED
- Drug class
- Interleukin-13 inhibitor (immunomodulator)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Tralokinumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02521288 | ADTRALZA | 150 MG | SOLUTION | LEO PHARMA INC | MARKETED |